Project cooperationUpdated on 11 December 2025
Healthentia - a Class IIa MDR app for chronic disease patients
CEO at Healthentia
Brussels, Belgium
About
Healthentia is a Class IIa MDR-certified Software as a Medical Device designed for chronic disease patients and for conducting high-quality clinical studies. Deployed across 10+ countries, it combines validated Remote Patient Monitoring, rich patient-reported outcomes, and seamless integration with IoT devices to support real-world evidence generation at scale.
Beyond medical-grade data collection, Healthentia introduces one of the most advanced digital health innovation layers in Europe: Agentic AI–powered Behavioral Change Coaching and Generative AI modules that deliver hyper-personalized lifestyle support, improving engagement, adherence, and long-term outcomes.
The platform is built on a robust regulatory foundation, ensuring full conformity with MDR, ISO 13485, IEC 62304, and AI Act obligations. This makes Healthentia an ideal partner for R&D consortia seeking a clinically proven, technologically cutting-edge, and regulation-ready platform for trials, digital therapeutics, AI research, longitudinal studies, and large-scale population health interventions.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Explainable AI for the Third, Digital Level of Care
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
Christina Salchow-Hömmen
Research & Innovation at XITASO GmbH
Berlin, Germany
Project cooperation
AI-Powered Chest X-Ray Diagnostic Assistant with Explainable AI
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Mohammad Khalaf
Research Assistant / Biomedical Engineering Student at Isik University
Istanbul, Türkiye
Project cooperation
VIOSync®: An AI-Driven Clinical Decision Support System for Early Risk Detection and Proactive Care
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
Ioannis Gkouzionis
CEO at Aisthesis Medical
London, United Kingdom